The American Medical Systems MDL is being heard by U.S. District Judge Joseph R. Goodwin, who is also presiding over six additional MDLs regarding transvaginal mesh products and their respective manufacturers. Women who claim to have been injured by certain transvaginal mesh devices charge manufacturers with releasing an unsafe product onto the market, one that allegedly causes mesh erosion, and as a result of this, organ damage. FDA & Transvaginal Mesh As plaintiffs question transvaginal mesh safety in lawsuits filed around the U.S., these medical devices are also on the radar of the U.S. Food and Drug Administration (FDA). In late April 2014, the FDA announced that they strongly recommend an update to the classification of transvaginal mesh products used to treat pelvic organ prolapse (POP).